Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer. Ahn SG, Kim SK, Shepherd JH, Cha YJ, et al. Breast Cancer Res Treat 2021 Mar 26. pii: 10.1007/s10549-021-06193.

Read + Share

Amedeo Smart

Independent Medical Education

Ahn SG, Kim SK, Shepherd JH, Cha YJ, et al. Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer. Breast Cancer Res Treat 2021 Mar 26. pii: 10.1007/s10549-021-06193.
PMID: 33770313